Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tinelli

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
International Journal of Immunopathology and Pharmacology|January 16, 2010
HLA-A*01 is associated with late onset of Alzheimer's disease in Italian patientsF R Guerini, C Tinelli, E Calabrese, et al.
HIV Clinical Trials|October 24, 2001
Antiviral potency of HAART regimens and clinical success are not strictly coupled in real life conditions: evidence from the MASTER-1 studyG Carosi, F Castelli, F Suter, et al.
American Journal of Perinatology|April 26, 2018
The Mother-Child Relationship during the First Months of Life: Preliminary Considerations in Preterm as Compared with Term Mother-Infant DyadsS Spairani, C Pisoni, G Ariaudo, et al.
Genes and Immunity|May 11, 2012
Possible KIR-driven genetic pressure on the genesis and maintenance of specific HLA-A,B haplotypes as functional genetic blocksC Capittini, C Tinelli, M Guarene, et al.
Oncology Reports|June 19, 2001
Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: a phase II studyS Brugnatelli, A Riccardi, M Danova, et al.
HIV Clinical Trials|October 30, 2003
Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: implications for timing to switchL R Tomasoni, A Patroni, C Torti, et al.
Rhinology|November 2, 2021
Epidemiological, clinical and endoscopic features of epistaxis severity and quality of life in Hereditary haemorrhagic telangiectasia: a cross-sectional studyF Pagella, E Maiorano, S Ugolini, et al.
Journal of Hepatology|October 6, 1997
Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of riskA Cividini, A Pistorio, A Regazzetti, et al.
The New England Journal of Medicine|October 6, 2000
Central diabetes insipidus in children and young adultsM Maghnie, G Cosi, E Genovese, et al.
International Journal of Oncology|March 16, 2000
Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancerA Riccardi, C Tinelli, S Brugnatelli, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
International Journal of Immunopathology and Pharmacology|January 16, 2010
HLA-A*01 is associated with late onset of Alzheimer's disease in Italian patientsF R Guerini, C Tinelli, E Calabrese, et al.
HIV Clinical Trials|October 24, 2001
Antiviral potency of HAART regimens and clinical success are not strictly coupled in real life conditions: evidence from the MASTER-1 studyG Carosi, F Castelli, F Suter, et al.
American Journal of Perinatology|April 26, 2018
The Mother-Child Relationship during the First Months of Life: Preliminary Considerations in Preterm as Compared with Term Mother-Infant DyadsS Spairani, C Pisoni, G Ariaudo, et al.
Genes and Immunity|May 11, 2012
Possible KIR-driven genetic pressure on the genesis and maintenance of specific HLA-A,B haplotypes as functional genetic blocksC Capittini, C Tinelli, M Guarene, et al.
Oncology Reports|June 19, 2001
Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: a phase II studyS Brugnatelli, A Riccardi, M Danova, et al.
HIV Clinical Trials|October 30, 2003
Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: implications for timing to switchL R Tomasoni, A Patroni, C Torti, et al.
Rhinology|November 2, 2021
Epidemiological, clinical and endoscopic features of epistaxis severity and quality of life in Hereditary haemorrhagic telangiectasia: a cross-sectional studyF Pagella, E Maiorano, S Ugolini, et al.
Journal of Hepatology|October 6, 1997
Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of riskA Cividini, A Pistorio, A Regazzetti, et al.
The New England Journal of Medicine|October 6, 2000
Central diabetes insipidus in children and young adultsM Maghnie, G Cosi, E Genovese, et al.
International Journal of Oncology|March 16, 2000
Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancerA Riccardi, C Tinelli, S Brugnatelli, et al.
Pageof 14